Rohit Vanjani

Oppenheimer & Co.

Image: Rohit Vanjani

Rohit Vanjani is executive director and senior analyst covering generics and specialty pharmaceuticals at Oppenheimer & Co. He has been with the firm since 2011, initially working on the Healthcare Services Team (healthcare IT, PBMs, and labs). Prior to Oppenheimer, Vanjani worked at Jefferies, UBS, and Leerink Swann, helping to cover the biotechnology, managed care and hospitals, and specialty pharmaceuticals verticals. He has also worked as an assistant economist at the Federal Reserve Bank of New York and as an economics associate at Stanford University, helping to conduct healthcare economic research. Prior to those roles, Vanjani worked as a laboratory associate researching enzyme active site residues and animal mitochondrial DNA. He holds a bachelor's degree in biochemistry and economics from the University of Michigan, and a master's degree in business administration from New York University's Stern School of Business.

Recent Quotes

"OPK anticipates a ~three-fold increase in Claros 1 cassette production."

— Rohit Vanjani, Oppenheimer & Co. (6/4/14)
more >



Due to permission requirements, not all quotes are shown.